Status:
COMPLETED
Tiagabine for the Treatment of Cocaine Dependence - 1
Lead Sponsor:
National Institute on Drug Abuse (NIDA)
Collaborating Sponsors:
University of Cincinnati
Conditions:
Cocaine-Related Disorders
Eligibility:
All Genders
18-99 years
Phase:
PHASE2
Brief Summary
The purpose of this study is to assess tiagabine for the treatment of cocaine dependence.
Detailed Description
To assess the efficacy and safety of tiagabine in reducing cocaine use in subjects with cocaine dependence. It is hypothesized that tiagabine treatment, compared to placebo, will be associated with fe...
Eligibility Criteria
Inclusion
- Must be at least 18 years of age and be seeking treatment for cocaine dependence. Have the ability to understand, and having understood, provide written informed consent. If female, agree to use a method of birth control as indicated by the clinician. Please contact the participating site in your area for more information.
Exclusion
- Please contact the participating site in your area for more information.
Key Trial Info
Start Date :
October 1 2002
Trial Type :
INTERVENTIONAL
End Date :
June 1 2004
Estimated Enrollment :
140 Patients enrolled
Trial Details
Trial ID
NCT00086255
Start Date
October 1 2002
End Date
June 1 2004
Last Update
January 12 2017
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Boston University Medical Center
Boston, Massachusetts, United States, 02215
2
Cincinnati VA Medical Center
Cincinnati, Ohio, United States, 45220
3
Dayton VA Medical Center
Dayton, Ohio, United States, 45428
4
University of Texas Hlth Sci Ctr Houston
Houston, Texas, United States, 77030